| Name | Title | Contact Details |
|---|
Integrative Emergency Services (IES) is a healthcare company that partners with Texas hospitals to provide the best patient encounter in emergency care. IES is transforming the way healthcare is practiced across the continuum of care and furthering the...
Cathedral Healthcare System is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cynvenio is a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood.
Sanbor Medical is a Allentown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.